January 12th, 2023
CREATION.co, one of the world’s leading healthcare consultancies for digital insights-led strategy, is delighted to announce that Mary Fletcher-Louis has joined the team as Head of Consulting and COO. Mary’s appointment to the company’s senior team will support the next phase of growth for CREATION.co’s expert consulting services.
Prior to joining CREATION.co, Mary was Vice President at DRG Abacus, leading its Value Communication Centre of Excellence. Mary has been serving the pharmaceutical industry for more than 25 years providing consulting and strategic leadership to clients around the world. She has a deep understanding of the industry, and the value that digital insights can bring to diverse teams involved in product development and launch. Mary also has a particular interest in training, and in the power of the workshop format to achieve team consensus and connection.
On her appointment, Mary said: “Work has always been a joy for me, and for my next role I was looking for a pioneering company with a big heart, that is committed to excellence, hungry to grow and will make use of the domain and people knowledge I've gained over the years. CREATION.co is a group of young, brilliant, humble people who are helping Pharma to understand the online HCP conversation in the service of patients. CREATION clients feedback that we bring unique confidence in executing strategy, in particular our experience in developing trusted, non-transactional partnerships with Digital Opinion Leaders.”
Daniel Ghinn, CEO of CREATION.co, said: “As the world moves towards a post-pandemic age, it’s an incredible time to be at the cutting edge of digital insights for health strategy. CREATION.co’s 25-year heritage on the front lines of digital health stakeholder intelligence is being drawn on by an increasing number of major global pharmaceutical clients. Mary’s extensive expertise in healthcare consulting brings timely additional capabilities to our growing team and will continue to strengthen CREATION.co’s reputation as a leader in insights-led health strategy.”